Takeaways of the phase III KATHERINE study in HER2+ early-stage breast cancer and considerations for treating with T-DM1 in the adjuvant setting.
For more resources and information regarding anticancer targeted therapies: [ Ссылка ]
Ещё видео!
Takeaways of the phase III KATHERINE study in HER2+ early-stage breast cancer and considerations for treating with T-DM1 in the adjuvant setting.
For more resources and information regarding anticancer targeted therapies: [ Ссылка ]